CASP9 and hepatocellular carcinoma: demonstrate that AAV6 serotype-based vexosomes, containing an inducible caspase 9 gene, are cytotoxic in the presence of a pro-drug AP20187 and have a significant therapeutic potential for suicide gene therapy in hepatocellular carcinoma.